Is CTT Pharmaceutical Holdings, Inc. (CTTH) a Buy, Sell, or Hold?
OTC : CTTH
CTT Pharmaceutical Holdings, Inc. — News
$0.066 USD
$0.0 (1.54%)
- Volume
- 43.85K
- Average Volume
- 20.61K
- Market Capitalization
- $3.94M
- P/E Ratio
- -26.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.10
- Year Low
- $0.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.20
| Source | Headline |
|---|---|
|
CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology
August 10, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the U.S. Patent Office for a continuation-in-part(CIP). A continuation-in-part (CIP) patent is a new application that repeats a substantial portion of an earlier “parent” application while adding brand new subject matter or improvements. The U.S. Patent Office has issued a patent number and will issue the patent on August 11, 2026. The CIP patent adds additional protection for nicotine, vitamins, and caffeine utilizing our micelle delivery technology. This new patent allows CTT Pharma the ability to use our technology to make dissolvable strips, gum, pouches, lozenges, and dissolving tablets. CTT will continue to spend time strengthening our patent portfolio as the company believes patents are an important aspect of the business. About CTT Pharmaceutical Holdings, Inc. thenewswire.com - 2026-08-10 06:00:00 |
|
CTT Pharma Receives SEC Approval
August 5, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the SEC for our S-1 and will now be a SEC reporting company. This is an important milestone as CTT Pharma is now an audited, SEC reporting company on the OTCQB and will start filing an SEC form 8-K when material events occur. CTT will update shareholders as more news becomes available. About CTT Pharmaceutical Holdings, Inc. thenewswire.com - 2026-08-05 06:00:00 |
|
CTT Pharma Signs LOI with European Company
May 14, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in Europe for a potential strategic partnership. A partnership with this group would allow CTT additional opportunities to monetize the company's patented technology in Europe and the United States. CTT Pharma will notify shareholders as more information becomes available. About CTT Pharmaceutical Holdings, Inc. thenewswire.com - 2026-05-14 06:00:00 |
